Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bertrand Routy

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Gut Microbes|October 20, 2018
The intimate relationship between gut microbiota and cancer immunotherapyArielle Elkrief, Lisa Derosa, Laurence Zitvogel, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studiesBrooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.
International Journal of Tryptophan Research : IJTR|October 25, 2016
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyJean-Pierre Routy, Bertrand Routy, Gina M Graziani, et al.
Nature Reviews. Microbiology|May 23, 2017
Anticancer effects of the microbiome and its productsLaurence Zitvogel, Romain Daillère, María Paula Roberti, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 27, 2015
Treatment with acetylsalicylic acid prevents short to mid-term radiographic progression of nontraumatic osteonecrosis of the femoral head: a pilot studyAnthony Albers, Alberto Carli, Bertrand Routy, et al.
European Urology Focus|January 31, 2025
What Is the Role of Fecal Microbiota Transplantation in Immunotherapy Trials? Current Perspectives and Future DirectionsEdmond Rafie, Miguel Zugman, Sumanta K Pal, et al.
Journal of Cancer|January 14, 2021
GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with CancerDarakhshan Sohail Ahmed, Stéphane Isnard, John Lin, et al.
Nature Reviews. Drug Discovery|June 2, 2025
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug developmentArielle Elkrief, Reilly Pidgeon, Saman Maleki Vareki, et al.
Nature Reviews. Clinical Oncology|April 12, 2018
The gut microbiota influences anticancer immunosurveillance and general healthBertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.
Cancer Discovery|August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Gut Microbes|October 20, 2018
The intimate relationship between gut microbiota and cancer immunotherapyArielle Elkrief, Lisa Derosa, Laurence Zitvogel, et al.
Cancer Immunology, Immunotherapy : CII|December 23, 2019
The effect of antibiotics on clinical outcomes in immune-checkpoint blockade: a systematic review and meta-analysis of observational studiesBrooke E Wilson, Bertrand Routy, Adnan Nagrial, et al.
International Journal of Tryptophan Research : IJTR|October 25, 2016
The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for ImmunotherapyJean-Pierre Routy, Bertrand Routy, Gina M Graziani, et al.
Nature Reviews. Microbiology|May 23, 2017
Anticancer effects of the microbiome and its productsLaurence Zitvogel, Romain Daillère, María Paula Roberti, et al.
Canadian Journal of Surgery. Journal Canadien De Chirurgie|May 27, 2015
Treatment with acetylsalicylic acid prevents short to mid-term radiographic progression of nontraumatic osteonecrosis of the femoral head: a pilot studyAnthony Albers, Alberto Carli, Bertrand Routy, et al.
European Urology Focus|January 31, 2025
What Is the Role of Fecal Microbiota Transplantation in Immunotherapy Trials? Current Perspectives and Future DirectionsEdmond Rafie, Miguel Zugman, Sumanta K Pal, et al.
Journal of Cancer|January 14, 2021
GDF15/GFRAL Pathway as a Metabolic Signature for Cachexia in Patients with CancerDarakhshan Sohail Ahmed, Stéphane Isnard, John Lin, et al.
Nature Reviews. Drug Discovery|June 2, 2025
The gut microbiome as a target in cancer immunotherapy: opportunities and challenges for drug developmentArielle Elkrief, Reilly Pidgeon, Saman Maleki Vareki, et al.
Nature Reviews. Clinical Oncology|April 12, 2018
The gut microbiota influences anticancer immunosurveillance and general healthBertrand Routy, Vancheswaran Gopalakrishnan, Romain Daillère, et al.
Cancer Discovery|August 17, 2021
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?Lisa Derosa, Bertrand Routy, Antoine Desilets, et al.
Pageof 13